sorafenib has been researched along with tranylcypromine in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (tranylcypromine) | Trials (tranylcypromine) | Recent Studies (post-2010) (tranylcypromine) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 1,826 | 94 | 183 |
Protein | Taxonomy | sorafenib (IC50) | tranylcypromine (IC50) |
---|---|---|---|
Lysine-specific histone demethylase 1A | Homo sapiens (human) | 4.64 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2E1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 3.585 | |
Cytochrome P450 2C8 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2A6 | Homo sapiens (human) | 2.7133 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 3.38 | |
Cytochrome P450 4B1 | Homo sapiens (human) | 6.2 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.078 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 6.4533 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2A7 | Homo sapiens (human) | 6.2 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.29 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.6436 | |
Cytochrome P450 3A7 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2F1 | Homo sapiens (human) | 6.2 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.0871 | |
Cytochrome P450 2C18 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 4.87 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4F2 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4F8 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4A11 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4F3 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2A13 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 4A22 | Homo sapiens (human) | 6.2 | |
Vitamin D 25-hydroxylase | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2U1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2W1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 2S1 | Homo sapiens (human) | 6.2 | |
Cytochrome P450 3A43 | Homo sapiens (human) | 6.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for sorafenib and tranylcypromine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |